0001179110-21-004517.txt : 20210419 0001179110-21-004517.hdr.sgml : 20210419 20210419173823 ACCESSION NUMBER: 0001179110-21-004517 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210415 FILED AS OF DATE: 20210419 DATE AS OF CHANGE: 20210419 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Greenbaum Lisa CENTRAL INDEX KEY: 0001791866 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39100 FILM NUMBER: 21835621 MAIL ADDRESS: STREET 1: C/O PROGYNY, INC. STREET 2: 245 5TH AVENUE CITY: NEW YORK STATE: NY ZIP: 10016 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Progyny, Inc. CENTRAL INDEX KEY: 0001551306 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090] IRS NUMBER: 272220139 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1359 BROADWAY STREET 2: 2ND FLOOR CITY: NEW YORK STATE: NY ZIP: 10018 BUSINESS PHONE: 212-888-3124 MAIL ADDRESS: STREET 1: 1359 BROADWAY STREET 2: 2ND FLOOR CITY: NEW YORK STATE: NY ZIP: 10018 FORMER COMPANY: FORMER CONFORMED NAME: Auxogyn, Inc. DATE OF NAME CHANGE: 20150318 FORMER COMPANY: FORMER CONFORMED NAME: Auxogyn Inc DATE OF NAME CHANGE: 20120601 4 1 edgar.xml FORM 4 - X0306 4 2021-04-15 0 0001551306 Progyny, Inc. PGNY 0001791866 Greenbaum Lisa C/O PROGYNY, INC. 1359 BROADWAY, 2ND FL NEW YORK NY 10018 0 1 0 0 EVP, Chief Client Officer Common Stock 2021-04-15 4 M 0 5000 3.95 A 16746 D Common Stock 2021-04-15 4 F 0 1588 51.21 D 15158 D Common Stock 2021-04-15 4 F 0 1059 50.97 D 14099 D Common Stock 2021-04-15 4 S 0 1412 50.59 D 12687 D Common Stock 2021-04-15 4 S 0 941 50.27 D 11746 D Employee Stock Option (right to buy) 3.95 2021-04-15 4 M 0 5000 0 D 2029-06-03 Common Stock 5000 150002 D Shares sold pursuant to a Rule 10b5-1 trading plan entered into on December 16, 2020. The price reported in Column 4 is a weighted average price. These shares were sold in several transactions at prices ranging from $50.27 to $50.40, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares withheld at each separate price within the range set forth in this footnote. One-fourth (1/4th) of the shares subject to the Option vested on June 3, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to the Option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. /s/ Jennifer Bealer, Attorney-in-Fact 2021-04-19